Literature DB >> 28806854

Generation of Xeno-Free, cGMP-Compliant Patient-Specific iPSCs from Skin Biopsy.

Luke A Wiley1,2, Kristin R Anfinson1,2, Cathryn M Cranston1,2, Emily E Kaalberg1,2, Malia M Collins1,2, Robert F Mullins1,2, Edwin M Stone1,2, Budd A Tucker1,2.   

Abstract

This unit describes protocols for the generation of clinical-grade patient-specific induced pluripotent stem cell (iPSC)-derived retinal cells from patients with inherited retinal degenerative blindness. Specifically, we describe how, using xeno-free reagents in an ISO class 5 environment, one can isolate and culture dermal fibroblasts, generate iPSCs, and derive autologous retinal cells via 3-D differentiation. The universal methods described herein for the isolation of dermal fibroblasts and generation of iPSCs can be employed regardless of disease, tissue, or cell type of interest. © 2017 by John Wiley & Sons, Inc.
Copyright © 2017 John Wiley & Sons, Inc.

Entities:  

Keywords:  cGMP; current Good Manufacturing Practice; fibroblasts; induced pluripotent stem cells; photoreceptor precursor cells; retina; xeno-free

Mesh:

Year:  2017        PMID: 28806854      PMCID: PMC5609845          DOI: 10.1002/cpsc.30

Source DB:  PubMed          Journal:  Curr Protoc Stem Cell Biol        ISSN: 1938-8969


  37 in total

1.  Self-formation of optic cups and storable stratified neural retina from human ESCs.

Authors:  Tokushige Nakano; Satoshi Ando; Nozomu Takata; Masako Kawada; Keiko Muguruma; Kiyotoshi Sekiguchi; Koichi Saito; Shigenobu Yonemura; Mototsugu Eiraku; Yoshiki Sasai
Journal:  Cell Stem Cell       Date:  2012-06-14       Impact factor: 24.633

2.  In vitro differentiation of retinal cells from human pluripotent stem cells by small-molecule induction.

Authors:  Fumitaka Osakada; Zi-Bing Jin; Yasuhiko Hirami; Hanako Ikeda; Teruko Danjyo; Kiichi Watanabe; Yoshiki Sasai; Masayo Takahashi
Journal:  J Cell Sci       Date:  2009-08-11       Impact factor: 5.285

3.  Integration-free induced pluripotent stem cells derived from retinitis pigmentosa patient for disease modeling.

Authors:  Zi-Bing Jin; Satoshi Okamoto; Ping Xiang; Masayo Takahashi
Journal:  Stem Cells Transl Med       Date:  2012-06-01       Impact factor: 6.940

4.  Rapid and efficient directed differentiation of human pluripotent stem cells into retinal pigmented epithelium.

Authors:  David E Buchholz; Britney O Pennington; Roxanne H Croze; Cassidy R Hinman; Peter J Coffey; Dennis O Clegg
Journal:  Stem Cells Transl Med       Date:  2013-04-18       Impact factor: 6.940

5.  Optic vesicle-like structures derived from human pluripotent stem cells facilitate a customized approach to retinal disease treatment.

Authors:  Jason S Meyer; Sara E Howden; Kyle A Wallace; Amelia D Verhoeven; Lynda S Wright; Elizabeth E Capowski; Isabel Pinilla; Jessica M Martin; Shulan Tian; Ron Stewart; Bikash Pattnaik; James A Thomson; David M Gamm
Journal:  Stem Cells       Date:  2011-08       Impact factor: 6.277

6.  Efficient generation of retinal progenitor cells from human embryonic stem cells.

Authors:  Deepak A Lamba; Mike O Karl; Carol B Ware; Thomas A Reh
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-14       Impact factor: 11.205

7.  Derivation of functional retinal pigmented epithelium from induced pluripotent stem cells.

Authors:  David E Buchholz; Sherry T Hikita; Teisha J Rowland; Amy M Friedrich; Cassidy R Hinman; Lincoln V Johnson; Dennis O Clegg
Journal:  Stem Cells       Date:  2009-10       Impact factor: 6.277

8.  Retinal repair by transplantation of photoreceptor precursors.

Authors:  R E MacLaren; R A Pearson; A MacNeil; R H Douglas; T E Salt; M Akimoto; A Swaroop; J C Sowden; R R Ali
Journal:  Nature       Date:  2006-11-09       Impact factor: 49.962

9.  Patient-specific iPSC-derived photoreceptor precursor cells as a means to investigate retinitis pigmentosa.

Authors:  Budd A Tucker; Robert F Mullins; Luan M Streb; Kristin Anfinson; Mari E Eyestone; Emily Kaalberg; Megan J Riker; Arlene V Drack; Terry A Braun; Edwin M Stone
Journal:  Elife       Date:  2013-08-27       Impact factor: 8.140

10.  Generation, purification and transplantation of photoreceptors derived from human induced pluripotent stem cells.

Authors:  Deepak A Lamba; Andrew McUsic; Roli K Hirata; Pei-Rong Wang; David Russell; Thomas A Reh
Journal:  PLoS One       Date:  2010-01-20       Impact factor: 3.240

View more
  9 in total

1.  CRISPR-Cas9-Based Genome Editing of Human Induced Pluripotent Stem Cells.

Authors:  Joseph C Giacalone; Tasneem P Sharma; Erin R Burnight; John F Fingert; Robert F Mullins; Edwin M Stone; Budd A Tucker
Journal:  Curr Protoc Stem Cell Biol       Date:  2018-02-28

Review 2.  Generation of defined neural populations from pluripotent stem cells.

Authors:  Sarah F McComish; Maeve A Caldwell
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-07-05       Impact factor: 6.237

3.  Local factor H production by human choroidal endothelial cells mitigates complement deposition: implications for macular degeneration.

Authors:  Kelly Mulfaul; Nathaniel K Mullin; Joseph C Giacalone; Andrew P Voigt; Melette R DeVore; Edwin M Stone; Budd A Tucker; Robert F Mullins
Journal:  J Pathol       Date:  2022-02-17       Impact factor: 9.883

4.  Feeder-free differentiation of cells exhibiting characteristics of corneal endothelium from human induced pluripotent stem cells.

Authors:  Michael D Wagoner; Laura R Bohrer; Benjamin T Aldrich; Mark A Greiner; Robert F Mullins; Kristan S Worthington; Budd A Tucker; Luke A Wiley
Journal:  Biol Open       Date:  2018-05-08       Impact factor: 2.422

5.  Correction of NR2E3 Associated Enhanced S-cone Syndrome Patient-specific iPSCs using CRISPR-Cas9.

Authors:  Laura R Bohrer; Luke A Wiley; Erin R Burnight; Jessica A Cooke; Joseph C Giacalone; Kristin R Anfinson; Jeaneen L Andorf; Robert F Mullins; Edwin M Stone; Budd A Tucker
Journal:  Genes (Basel)       Date:  2019-04-05       Impact factor: 4.096

6.  Optimizing Donor Cellular Dissociation and Subretinal Injection Parameters for Stem Cell-Based Treatments.

Authors:  Brittni A Scruggs; Chunhua Jiao; Cathryn M Cranston; Emily Kaalberg; Kai Wang; Stephen R Russell; Luke A Wiley; Robert F Mullins; Edwin M Stone; Budd A Tucker; Elliott H Sohn
Journal:  Stem Cells Transl Med       Date:  2019-04-19       Impact factor: 6.940

7.  Transplantation of GMP-grade human iPSC-derived retinal pigment epithelial cells in rodent model: the first pre-clinical study for safety and efficacy in China.

Authors:  Hang Zhang; Bingnan Su; Luyan Jiao; Ze-Hua Xu; Chang-Jun Zhang; Jinfu Nie; Mei-Ling Gao; Ying V Zhang; Zi-Bing Jin
Journal:  Ann Transl Med       Date:  2021-02

8.  Biocompatibility of Human Induced Pluripotent Stem Cell-Derived Retinal Progenitor Cell Grafts in Immunocompromised Rats.

Authors:  Ian C Han; Laura R Bohrer; Katherine N Gibson-Corley; Luke A Wiley; Arwin Shrestha; Brynnon E Harman; Chunhua Jiao; Elliott H Sohn; Rion Wendland; Brittany N Allen; Kristan S Worthington; Robert F Mullins; Edwin M Stone; Budd A Tucker
Journal:  Cell Transplant       Date:  2022 Jan-Dec       Impact factor: 4.139

Review 9.  Microfluidic processing of stem cells for autologous cell replacement.

Authors:  Nicholas E Stone; Andrew P Voigt; Robert F Mullins; Todd Sulchek; Budd A Tucker
Journal:  Stem Cells Transl Med       Date:  2021-06-22       Impact factor: 6.940

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.